US medicines agency and Pfizer consider Covid-19 vaccine side effects
Two people in Alaska who received the Pfizer-BioNTech vaccine suffered allergic reactions, which have also been seen in vaccine recipients in the UK
17 December 2020 - 18:17
Pfizer and US drug regulators are revising information for use and monitoring of the company’s Covid-19 vaccine developed with BioNTech, after rare allergic reactions were seen in some recipients.
The revisions reflect guidelines from the Centers for Disease Control and Prevention (CDC) for following vaccine recipients and managing potential reactions, Doran Fink, deputy director of Food and Drug Administration’s (FDA’s) division of vaccines and related products applications, said on Thursday in a meeting of FDA advisers...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.